Yan Leyfman, Medical Oncologist, Co-Founder and Executive Director of MedNews Week, shared a post by Jeremy Bellaiche, Founder of Shuf, on LinkedIn adding:
“Introducing The Translational Edge — a new podcast series where we break down cutting-edge science, decode complex data, and spotlight the innovations that are reshaping medicine.
I’m thrilled to launch this initiative alongside Jeremy Bellaiche and Shuf, two phenomenal partners deeply committed to elevating scientific communication and making medical breakthroughs understandable and actionable for everyone.
Episode 1 is now live: ‘Does Keppra Actually Help CAR-T Patients? The Surprising Answer.’
What you can expect from this series:
- Clear, accessible discussions on breakthrough research
- Deep dives into the science behind today’s most innovative therapies
- Conversations that bridge the gap between the lab bench and real-world patient care
- Highlights of the pioneering work taking place across oncology, immunology, biotech, and beyond
Exciting episodes are on the way — featuring transformative studies, emerging technologies, and the trailblazers pushing the boundaries of modern medicine.
If you want to stay at the forefront of scientific innovation:
Share
Subscribe
Follow
…and join us on this journey at The Translational Edge.
Let’s continue reconciling healthcare professionals with meaningful, evidence-based medical content — one episode at a time.”
Quoting Jeremy Bellaiche’s post:
“So humble to collaborate with top experts like Yan Leyfman from MedNews Week!
This is the first episode of The Translational Edge, ‘Does Keppra Actually Help CAR-T Patients? The Surprising Answer’.
Exclusively on Shuf! Let’s reconcile HCPs with medical content!”
Listen to the full episode.